News Flip flop policy over pioglitazone licence causes media storm in India BMJ 2013; 347 doi: https://doi.org/10.1136/bmj.f4937 (Published 06 August 2013) Cite this as: BMJ 2013;347:f4937 Article Related content Metrics Responses Peer review Related articles News India’s health ministry bans pioglitazone, metamizole, and flupentixol-melitracen Published: 05 July 2013; BMJ 347 doi:10.1136/bmj.f4366 Editor's choiceFlouting evidence in a rush to the market: do we know enough about the drugs we prescribe?
